Many human tumors exhibit EGFR overexpression, which is correlated with an advanced tumor stage or a poor clinical outcome, such as non-small cell lung cancer [38], colorectal cancer [39], breast cancer [40], head and neck cancer [41], bladder cancer [42], and GC [43]. Here, EGFR is linked to breast carcinoma.